nodes	percent_of_prediction	percent_of_DWPC	metapath
Vemurafenib—BRAF—adrenal gland cancer	0.862	1	CbGaD
Vemurafenib—Etoricoxib—PTGS2—adrenal gland cancer	0.00241	1	CrCbGaD
Vemurafenib—CYP1A2—urine—adrenal gland cancer	0.00181	0.113	CbGeAlD
Vemurafenib—BRAF—pituitary gland—adrenal gland cancer	0.00146	0.0912	CbGeAlD
Vemurafenib—CYP3A4—urine—adrenal gland cancer	0.00131	0.0818	CbGeAlD
Vemurafenib—BRAF—adrenal gland—adrenal gland cancer	0.0013	0.0815	CbGeAlD
Vemurafenib—CYP2D6—urine—adrenal gland cancer	0.00129	0.0805	CbGeAlD
Vemurafenib—RAF1—adrenal cortex—adrenal gland cancer	0.0012	0.0752	CbGeAlD
Vemurafenib—RAF1—gonad—adrenal gland cancer	0.000997	0.0623	CbGeAlD
Vemurafenib—RAF1—cardiac atrium—adrenal gland cancer	0.000995	0.0622	CbGeAlD
Vemurafenib—RAF1—pituitary gland—adrenal gland cancer	0.000972	0.0608	CbGeAlD
Vemurafenib—RAF1—adrenal gland—adrenal gland cancer	0.000869	0.0543	CbGeAlD
Vemurafenib—ABCC1—adrenal cortex—adrenal gland cancer	0.000601	0.0376	CbGeAlD
Vemurafenib—ALB—adrenal gland—adrenal gland cancer	0.000526	0.0329	CbGeAlD
Vemurafenib—ABCG2—adrenal cortex—adrenal gland cancer	0.000498	0.0311	CbGeAlD
Vemurafenib—ABCC1—cardiac atrium—adrenal gland cancer	0.000497	0.0311	CbGeAlD
Vemurafenib—ABCC1—pituitary gland—adrenal gland cancer	0.000486	0.0304	CbGeAlD
Vemurafenib—ABCC1—adrenal gland—adrenal gland cancer	0.000434	0.0271	CbGeAlD
Vemurafenib—ABCG2—pituitary gland—adrenal gland cancer	0.000402	0.0251	CbGeAlD
Vemurafenib—ABCG2—adrenal gland—adrenal gland cancer	0.000359	0.0224	CbGeAlD
Vemurafenib—RAF1—NGF signalling via TRKA from the plasma membrane—BAD—adrenal gland cancer	0.000106	0.000887	CbGpPWpGaD
Vemurafenib—RAF1—Axon guidance—CDC42—adrenal gland cancer	0.000106	0.000884	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000104	0.000867	CbGpPWpGaD
Vemurafenib—BRAF—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.000104	0.000865	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—SPARC—adrenal gland cancer	0.000103	0.000865	CbGpPWpGaD
Vemurafenib—RAF1—Focal Adhesion—BRAF—adrenal gland cancer	0.000103	0.000861	CbGpPWpGaD
Vemurafenib—RAF1—Disease—SH3KBP1—adrenal gland cancer	0.000103	0.000857	CbGpPWpGaD
Vemurafenib—BRAF—Integrated Breast Cancer Pathway—EGFR—adrenal gland cancer	0.000102	0.000856	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—SH3KBP1—adrenal gland cancer	0.000102	0.00085	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—SDHB—adrenal gland cancer	0.0001	0.000837	CbGpPWpGaD
Vemurafenib—RAF1—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	9.89e-05	0.000826	CbGpPWpGaD
Vemurafenib—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	9.88e-05	0.000825	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—ZNRF3—adrenal gland cancer	9.76e-05	0.000816	CbGpPWpGaD
Vemurafenib—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—adrenal gland cancer	9.74e-05	0.000814	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways in Glioblastoma—TP53—adrenal gland cancer	9.7e-05	0.000811	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by FGFR—EGFR—adrenal gland cancer	9.69e-05	0.000809	CbGpPWpGaD
Vemurafenib—BRAF—EGF/EGFR Signaling Pathway—EGFR—adrenal gland cancer	9.69e-05	0.000809	CbGpPWpGaD
Vemurafenib—RAF1—NGF signalling via TRKA from the plasma membrane—BRAF—adrenal gland cancer	9.66e-05	0.000807	CbGpPWpGaD
Vemurafenib—RAF1—Disease—ZNRF3—adrenal gland cancer	9.64e-05	0.000806	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—ZNRF3—adrenal gland cancer	9.56e-05	0.000799	CbGpPWpGaD
Vemurafenib—RAF1—ErbB1 downstream signaling—EGFR—adrenal gland cancer	9.48e-05	0.000792	CbGpPWpGaD
Vemurafenib—CYP2D6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	9.45e-05	0.00079	CbGpPWpGaD
Vemurafenib—BRAF—MAPK Signaling Pathway—EGFR—adrenal gland cancer	9.41e-05	0.000786	CbGpPWpGaD
Vemurafenib—RAF1—BDNF signaling pathway—CTNNB1—adrenal gland cancer	9.29e-05	0.000777	CbGpPWpGaD
Vemurafenib—RAF1—Retinoblastoma (RB) in Cancer—TP53—adrenal gland cancer	9.25e-05	0.000773	CbGpPWpGaD
Vemurafenib—CYP1A2—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	9.12e-05	0.000762	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by FGFR in disease—EGFR—adrenal gland cancer	9.02e-05	0.000754	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—SDHB—adrenal gland cancer	8.81e-05	0.000736	CbGpPWpGaD
Vemurafenib—BRAF—Disease—SPRY2—adrenal gland cancer	8.74e-05	0.00073	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—PRKACA—adrenal gland cancer	8.73e-05	0.00073	CbGpPWpGaD
Vemurafenib—BRAF—Integrated Breast Cancer Pathway—TP53—adrenal gland cancer	8.6e-05	0.000719	CbGpPWpGaD
Vemurafenib—BRAF—Focal Adhesion—EGFR—adrenal gland cancer	8.53e-05	0.000713	CbGpPWpGaD
Vemurafenib—ALB—Selenium Micronutrient Network—PTGS2—adrenal gland cancer	8.29e-05	0.000693	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	8.29e-05	0.000693	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—BAD—adrenal gland cancer	8.16e-05	0.000682	CbGpPWpGaD
Vemurafenib—CYP1A2—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	8.01e-05	0.000669	CbGpPWpGaD
Vemurafenib—BRAF—Disease—MEN1—adrenal gland cancer	8e-05	0.000669	CbGpPWpGaD
Vemurafenib—BRAF—NGF signalling via TRKA from the plasma membrane—EGFR—adrenal gland cancer	7.99e-05	0.000668	CbGpPWpGaD
Vemurafenib—RAF1—Senescence and Autophagy in Cancer—TP53—adrenal gland cancer	7.96e-05	0.000665	CbGpPWpGaD
Vemurafenib—BRAF—MAPK Signaling Pathway—TP53—adrenal gland cancer	7.9e-05	0.00066	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	7.88e-05	0.000659	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—PRKACA—adrenal gland cancer	7.86e-05	0.000657	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—GNRH1—adrenal gland cancer	7.83e-05	0.000655	CbGpPWpGaD
Vemurafenib—ALB—Platelet activation, signaling and aggregation—CDC42—adrenal gland cancer	7.73e-05	0.000646	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—GNRHR—adrenal gland cancer	7.73e-05	0.000646	CbGpPWpGaD
Vemurafenib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	7.62e-05	0.000637	CbGpPWpGaD
Vemurafenib—RAF1—Neuronal System—BRAF—adrenal gland cancer	7.58e-05	0.000633	CbGpPWpGaD
Vemurafenib—RAF1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	7.56e-05	0.000632	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—CDC42—adrenal gland cancer	7.55e-05	0.000631	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—PRKACA—adrenal gland cancer	7.55e-05	0.000631	CbGpPWpGaD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	7.49e-05	0.000626	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by SCF-KIT—EGFR—adrenal gland cancer	7.49e-05	0.000626	CbGpPWpGaD
Vemurafenib—ALB—Platelet activation, signaling and aggregation—IGF2—adrenal gland cancer	7.45e-05	0.000623	CbGpPWpGaD
Vemurafenib—RAF1—Focal Adhesion—CTNNB1—adrenal gland cancer	7.45e-05	0.000622	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—BRAF—adrenal gland cancer	7.43e-05	0.000621	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	7.41e-05	0.00062	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—CDC42—adrenal gland cancer	7.41e-05	0.000619	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—SH3KBP1—adrenal gland cancer	7.18e-05	0.0006	CbGpPWpGaD
Vemurafenib—RAF1—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	7.17e-05	0.000599	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signaling of activated FGFR—EGFR—adrenal gland cancer	7.17e-05	0.000599	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—IGF2—adrenal gland cancer	7.14e-05	0.000597	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—GNAS—adrenal gland cancer	7.08e-05	0.000591	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB4—EGFR—adrenal gland cancer	7.05e-05	0.000589	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—TSHR—adrenal gland cancer	6.98e-05	0.000584	CbGpPWpGaD
Vemurafenib—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	6.91e-05	0.000577	CbGpPWpGaD
Vemurafenib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	6.91e-05	0.000577	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—ZNRF3—adrenal gland cancer	6.75e-05	0.000564	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signal transduction—EGFR—adrenal gland cancer	6.73e-05	0.000563	CbGpPWpGaD
Vemurafenib—RAF1—EGF/EGFR Signaling Pathway—EGFR—adrenal gland cancer	6.7e-05	0.00056	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR—EGFR—adrenal gland cancer	6.7e-05	0.00056	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—GNRH1—adrenal gland cancer	6.69e-05	0.000559	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB2—EGFR—adrenal gland cancer	6.67e-05	0.000557	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—CDC42—adrenal gland cancer	6.67e-05	0.000557	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 signaling—EGFR—adrenal gland cancer	6.64e-05	0.000555	CbGpPWpGaD
Vemurafenib—RAF1—TGF-beta Signaling Pathway—TP53—adrenal gland cancer	6.63e-05	0.000554	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	6.59e-05	0.000551	CbGpPWpGaD
Vemurafenib—RAF1—MAPK Signaling Pathway—EGFR—adrenal gland cancer	6.51e-05	0.000544	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—RRM1—adrenal gland cancer	6.45e-05	0.000539	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—SDHD—adrenal gland cancer	6.45e-05	0.000539	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—CDC42—adrenal gland cancer	6.4e-05	0.000535	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 interactions—EGFR—adrenal gland cancer	6.24e-05	0.000522	CbGpPWpGaD
Vemurafenib—RAF1—Fc epsilon receptor (FCERI) signaling—EGFR—adrenal gland cancer	6.24e-05	0.000522	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR in disease—EGFR—adrenal gland cancer	6.24e-05	0.000522	CbGpPWpGaD
Vemurafenib—ALB—Folate Metabolism—TP53—adrenal gland cancer	6.21e-05	0.000519	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR—EGFR—adrenal gland cancer	6.19e-05	0.000517	CbGpPWpGaD
Vemurafenib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	6.18e-05	0.000516	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by NGF—EGFR—adrenal gland cancer	6.15e-05	0.000514	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR in Cancer—EGFR—adrenal gland cancer	6.13e-05	0.000512	CbGpPWpGaD
Vemurafenib—RAF1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	6.13e-05	0.000512	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—SPRY2—adrenal gland cancer	6.12e-05	0.000511	CbGpPWpGaD
Vemurafenib—BRAF—Disease—PRKACA—adrenal gland cancer	6.11e-05	0.000511	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by PDGF—EGFR—adrenal gland cancer	6.11e-05	0.00051	CbGpPWpGaD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	6.07e-05	0.000508	CbGpPWpGaD
Vemurafenib—RAF1—Disease—SPRY2—adrenal gland cancer	6.04e-05	0.000505	CbGpPWpGaD
Vemurafenib—RAF1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	6.01e-05	0.000502	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—SPRY2—adrenal gland cancer	5.99e-05	0.000501	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—TSHR—adrenal gland cancer	5.96e-05	0.000498	CbGpPWpGaD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	5.96e-05	0.000498	CbGpPWpGaD
Vemurafenib—RAF1—Focal Adhesion—EGFR—adrenal gland cancer	5.9e-05	0.000493	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	5.87e-05	0.000491	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	5.87e-05	0.00049	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—SDHD—adrenal gland cancer	5.68e-05	0.000474	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—RRM1—adrenal gland cancer	5.68e-05	0.000474	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—MEN1—adrenal gland cancer	5.61e-05	0.000468	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—SPARC—adrenal gland cancer	5.57e-05	0.000465	CbGpPWpGaD
Vemurafenib—RAF1—Disease—MEN1—adrenal gland cancer	5.54e-05	0.000463	CbGpPWpGaD
Vemurafenib—RAF1—NGF signalling via TRKA from the plasma membrane—EGFR—adrenal gland cancer	5.53e-05	0.000462	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—MEN1—adrenal gland cancer	5.49e-05	0.000459	CbGpPWpGaD
Vemurafenib—RAF1—MAPK Signaling Pathway—TP53—adrenal gland cancer	5.47e-05	0.000457	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—SDHB—adrenal gland cancer	5.44e-05	0.000454	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	5.34e-05	0.000447	CbGpPWpGaD
Vemurafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	5.34e-05	0.000447	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	5.24e-05	0.000438	CbGpPWpGaD
Vemurafenib—BRAF—Disease—CDC42—adrenal gland cancer	5.18e-05	0.000433	CbGpPWpGaD
Vemurafenib—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	5.02e-05	0.00042	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—PRKACA—adrenal gland cancer	5.01e-05	0.000419	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	4.93e-05	0.000412	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—MED12—adrenal gland cancer	4.81e-05	0.000402	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—PRKACA—adrenal gland cancer	4.7e-05	0.000393	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—BAD—adrenal gland cancer	4.65e-05	0.000389	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—GNRH1—adrenal gland cancer	4.63e-05	0.000387	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—PRKACA—adrenal gland cancer	4.58e-05	0.000383	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—SDHB—adrenal gland cancer	4.49e-05	0.000375	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—BAD—adrenal gland cancer	4.47e-05	0.000373	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	4.3e-05	0.000359	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—PRKACA—adrenal gland cancer	4.28e-05	0.000358	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	4.28e-05	0.000358	CbGpPWpGaD
Vemurafenib—CYP1A2—Biological oxidations—POMC—adrenal gland cancer	4.25e-05	0.000355	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—EGFR—adrenal gland cancer	4.25e-05	0.000355	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—CDC42—adrenal gland cancer	4.25e-05	0.000355	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—MED12—adrenal gland cancer	4.23e-05	0.000354	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—SPRY2—adrenal gland cancer	4.23e-05	0.000354	CbGpPWpGaD
Vemurafenib—RAF1—Disease—PRKACA—adrenal gland cancer	4.23e-05	0.000353	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—PRKACA—adrenal gland cancer	4.19e-05	0.00035	CbGpPWpGaD
Vemurafenib—BRAF—Disease—TERT—adrenal gland cancer	4.16e-05	0.000347	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—TSHR—adrenal gland cancer	4.12e-05	0.000345	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	4.1e-05	0.000343	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	4.07e-05	0.00034	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—GNAS—adrenal gland cancer	4.06e-05	0.000339	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—CDC42—adrenal gland cancer	3.99e-05	0.000333	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CDC42—adrenal gland cancer	3.88e-05	0.000325	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—MEN1—adrenal gland cancer	3.88e-05	0.000324	CbGpPWpGaD
Vemurafenib—RAF1—Axon guidance—EGFR—adrenal gland cancer	3.85e-05	0.000322	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—IGF2—adrenal gland cancer	3.84e-05	0.000321	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—GNAS—adrenal gland cancer	3.81e-05	0.000318	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—SDHB—adrenal gland cancer	3.8e-05	0.000318	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CDC42—adrenal gland cancer	3.63e-05	0.000303	CbGpPWpGaD
Vemurafenib—BRAF—Disease—BAD—adrenal gland cancer	3.62e-05	0.000302	CbGpPWpGaD
Vemurafenib—RAF1—Disease—CDC42—adrenal gland cancer	3.59e-05	0.0003	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—CDC42—adrenal gland cancer	3.55e-05	0.000297	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—PRKACA—adrenal gland cancer	3.51e-05	0.000293	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—SDHD—adrenal gland cancer	3.5e-05	0.000293	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—RRM1—adrenal gland cancer	3.5e-05	0.000293	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—IGF2—adrenal gland cancer	3.5e-05	0.000292	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—GNAS—adrenal gland cancer	3.47e-05	0.00029	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—CTNNB1—adrenal gland cancer	3.47e-05	0.00029	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	3.43e-05	0.000287	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—IGF1R—adrenal gland cancer	3.38e-05	0.000283	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	3.3e-05	0.000276	CbGpPWpGaD
Vemurafenib—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	3.28e-05	0.000274	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	3.24e-05	0.00027	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—PRKACA—adrenal gland cancer	3.09e-05	0.000258	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—CTNNB1—adrenal gland cancer	3.06e-05	0.000256	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	2.99e-05	0.00025	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—PRKACA—adrenal gland cancer	2.96e-05	0.000247	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—SDHB—adrenal gland cancer	2.93e-05	0.000245	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—TERT—adrenal gland cancer	2.91e-05	0.000243	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—RRM1—adrenal gland cancer	2.89e-05	0.000242	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—SDHD—adrenal gland cancer	2.89e-05	0.000242	CbGpPWpGaD
Vemurafenib—RAF1—Disease—TERT—adrenal gland cancer	2.88e-05	0.00024	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—TERT—adrenal gland cancer	2.85e-05	0.000238	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—GNAS—adrenal gland cancer	2.84e-05	0.000238	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—ABCB1—adrenal gland cancer	2.79e-05	0.000233	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—EGFR—adrenal gland cancer	2.75e-05	0.00023	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—POMC—adrenal gland cancer	2.73e-05	0.000229	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—BAD—adrenal gland cancer	2.71e-05	0.000227	CbGpPWpGaD
Vemurafenib—BRAF—Disease—PTGS2—adrenal gland cancer	2.66e-05	0.000222	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—MED12—adrenal gland cancer	2.61e-05	0.000218	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—BAD—adrenal gland cancer	2.53e-05	0.000212	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CDC42—adrenal gland cancer	2.51e-05	0.00021	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—GNAS—adrenal gland cancer	2.5e-05	0.000209	CbGpPWpGaD
Vemurafenib—RAF1—Disease—BAD—adrenal gland cancer	2.5e-05	0.000209	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—BAD—adrenal gland cancer	2.48e-05	0.000207	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—ABCB1—adrenal gland cancer	2.46e-05	0.000205	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—RRM1—adrenal gland cancer	2.45e-05	0.000205	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—SDHD—adrenal gland cancer	2.45e-05	0.000205	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—EGFR—adrenal gland cancer	2.43e-05	0.000203	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—IGF2—adrenal gland cancer	2.42e-05	0.000202	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—GNAS—adrenal gland cancer	2.4e-05	0.000201	CbGpPWpGaD
Vemurafenib—BRAF—Disease—CTNNB1—adrenal gland cancer	2.38e-05	0.000199	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—IGF1R—adrenal gland cancer	2.34e-05	0.000196	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—POMC—adrenal gland cancer	2.34e-05	0.000195	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	2.33e-05	0.000195	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—EGFR—adrenal gland cancer	2.33e-05	0.000195	CbGpPWpGaD
Vemurafenib—RAF1—Disease—BRAF—adrenal gland cancer	2.28e-05	0.00019	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—TP53—adrenal gland cancer	2.26e-05	0.000189	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—BRAF—adrenal gland cancer	2.26e-05	0.000189	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—MED12—adrenal gland cancer	2.16e-05	0.00018	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—TERT—adrenal gland cancer	2.01e-05	0.000168	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—POMC—adrenal gland cancer	1.92e-05	0.00016	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PRKACA—adrenal gland cancer	1.91e-05	0.000159	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—RRM1—adrenal gland cancer	1.89e-05	0.000158	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—SDHD—adrenal gland cancer	1.89e-05	0.000158	CbGpPWpGaD
Vemurafenib—BRAF—Disease—EGFR—adrenal gland cancer	1.89e-05	0.000158	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.86e-05	0.000156	CbGpPWpGaD
Vemurafenib—RAF1—Disease—PTGS2—adrenal gland cancer	1.84e-05	0.000154	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—MED12—adrenal gland cancer	1.83e-05	0.000153	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—PTGS2—adrenal gland cancer	1.82e-05	0.000152	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CTNNB1—adrenal gland cancer	1.78e-05	0.000149	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—BAD—adrenal gland cancer	1.75e-05	0.000146	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—POMC—adrenal gland cancer	1.69e-05	0.000141	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CTNNB1—adrenal gland cancer	1.67e-05	0.000139	CbGpPWpGaD
Vemurafenib—RAF1—Disease—CTNNB1—adrenal gland cancer	1.65e-05	0.000138	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.63e-05	0.000136	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—CTNNB1—adrenal gland cancer	1.63e-05	0.000136	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—POMC—adrenal gland cancer	1.62e-05	0.000135	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—BRAF—adrenal gland cancer	1.6e-05	0.000133	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	1.57e-05	0.000131	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—EGFR—adrenal gland cancer	1.55e-05	0.000129	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—GNAS—adrenal gland cancer	1.54e-05	0.000129	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—PTGS2—adrenal gland cancer	1.53e-05	0.000128	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—ABCB1—adrenal gland cancer	1.52e-05	0.000127	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—EGFR—adrenal gland cancer	1.41e-05	0.000118	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—MED12—adrenal gland cancer	1.41e-05	0.000118	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—PTGS2—adrenal gland cancer	1.34e-05	0.000112	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PRKACA—adrenal gland cancer	1.33e-05	0.000111	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—EGFR—adrenal gland cancer	1.32e-05	0.00011	CbGpPWpGaD
Vemurafenib—RAF1—Disease—EGFR—adrenal gland cancer	1.3e-05	0.000109	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.3e-05	0.000109	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—EGFR—adrenal gland cancer	1.29e-05	0.000108	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GNAS—adrenal gland cancer	1.28e-05	0.000107	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	1.25e-05	0.000105	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—TP53—adrenal gland cancer	1.22e-05	0.000102	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CTNNB1—adrenal gland cancer	1.15e-05	9.64e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—TP53—adrenal gland cancer	1.11e-05	9.26e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GNAS—adrenal gland cancer	1.08e-05	9.03e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ABCB1—adrenal gland cancer	1.06e-05	8.86e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—POMC—adrenal gland cancer	1.04e-05	8.69e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	1.03e-05	8.6e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—EGFR—adrenal gland cancer	9.13e-06	7.63e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—POMC—adrenal gland cancer	8.59e-06	7.18e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GNAS—adrenal gland cancer	8.34e-06	6.97e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PTGS2—adrenal gland cancer	8.29e-06	6.93e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	8.18e-06	6.84e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—TP53—adrenal gland cancer	7.67e-06	6.41e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—POMC—adrenal gland cancer	7.27e-06	6.08e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	6.85e-06	5.72e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PTGS2—adrenal gland cancer	5.8e-06	4.85e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—POMC—adrenal gland cancer	5.61e-06	4.69e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	4.48e-06	3.74e-05	CbGpPWpGaD
